{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T12:50:11Z","timestamp":1751374211712,"version":"3.38.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100018542","name":"Natural Science Foundation of Sichuan Province","doi-asserted-by":"publisher","award":["22NSFSC2421","2022NSFSC0736"],"award-info":[{"award-number":["22NSFSC2421","2022NSFSC0736"]}],"id":[{"id":"10.13039\/501100018542","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.cca.2025.120206","type":"journal-article","created":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T23:59:00Z","timestamp":1739923140000},"page":"120206","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Proatherogenic changes in the quantity and quality of lipoproteins in adults with idiopathic nephrotic syndrome"],"prefix":"10.1016","volume":"570","author":[{"given":"Qiuxiao","family":"Jiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanhua","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangyi","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunmei","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruyi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuyu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Gan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.cca.2025.120206_b0005","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/s41581-019-0217-5","article-title":"Molecular stratification of idiopathic nephrotic syndrome","volume":"15","author":"Saleem","year":"2019","journal-title":"Nat Rev Nephrol"},{"issue":"8","key":"10.1016\/j.cca.2025.120206_b0010","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1007\/s40620-023-01697-7","article-title":"Nephrotic syndrome: pathophysiology and consequences","volume":"36","author":"Claudio","year":"2023","journal-title":"J. Nephrol."},{"issue":"1","key":"10.1016\/j.cca.2025.120206_b0015","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.kint.2016.02.026","article-title":"Disorders of lipid metabolism in nephrotic syndrome: mechanisms and consequences","volume":"90","author":"Vaziri","year":"2016","journal-title":"Kidney Int."},{"issue":"1","key":"10.1016\/j.cca.2025.120206_b0020","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nrneph.2017.155","article-title":"Dyslipidaemia in nephrotic syndrome: mechanisms and treatment","volume":"14","author":"Agrawal","year":"2018","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.cca.2025.120206_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101222","article-title":"HDL subclass proteomic analysis and functional implication of protein dynamic change during HDL maturation","volume":"24","author":"Zhang","year":"2019","journal-title":"Redox Biol"},{"issue":"24","key":"10.1016\/j.cca.2025.120206_b0030","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1093\/eurheartj\/ehz962","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel","volume":"41","author":"Bor\u00e9n","year":"2020","journal-title":"Eur. Heart J."},{"issue":"4","key":"10.1016\/j.cca.2025.120206_b0035","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.pcad.2020.04.009","article-title":"Small dense low-density lipoprotein-cholesterol (sdLDL-C): Analysis, effects on cardiovascular endpoints and dietary strategies","volume":"63","author":"Santos","year":"2020","journal-title":"Prog Cardiovasc Dis"},{"issue":"7","key":"10.1016\/j.cca.2025.120206_b0040","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1001\/jamacardio.2022.0912","article-title":"Association Between High-Density Lipoprotein Cholesterol Levels and Adverse Cardiovascular Outcomes in High-risk Populations","volume":"7","author":"Liu","year":"2022","journal-title":"JAMA Cardiol"},{"issue":"25","key":"10.1016\/j.cca.2025.120206_b0045","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1056\/NEJMoa1409065","article-title":"HDL cholesterol efflux capacity and incident cardiovascular events","volume":"371","author":"Rohatgi","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.cca.2025.120206_b0050","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1161\/ATVBAHA.113.301373","article-title":"Paradoxical association of enhanced cholesterol efflux with increased incident cardiovascular risks","volume":"33","author":"Li","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"3","key":"10.1016\/j.cca.2025.120206_b0055","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1194\/jlr.M031336","article-title":"Serum albumin acts as a shuttle to enhance cholesterol efflux from cells","volume":"54","author":"Sankaranarayanan","year":"2013","journal-title":"J. Lipid Res."},{"issue":"2\u20133","key":"10.1016\/j.cca.2025.120206_b0060","first-page":"119","article-title":"Human serum albumin and its structural variants mediate cholesterol efflux from cultured endothelial cells","volume":"1640","author":"Ha","year":"2003","journal-title":"BBA"},{"issue":"2","key":"10.1016\/j.cca.2025.120206_b0065","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0021-9150(85)90181-9","article-title":"Lipoprotein distribution and composition in the human nephrotic syndrome","volume":"54","author":"Muls","year":"1985","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.cca.2025.120206_b0070","article-title":"Lipoproteins and cholesterol homeostasis in paediatric nephrotic syndrome patients","volume":"32","author":"Simachew","year":"2022","journal-title":"Biochem Med (Zagreb)"},{"issue":"7654","key":"10.1016\/j.cca.2025.120206_b0075","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1136\/bmj.39576.709711.80","article-title":"Nephrotic syndrome in adults","volume":"336","author":"Hull","year":"2008","journal-title":"BMJ (Clinical Research Ed.)"},{"issue":"4S","key":"10.1016\/j.cca.2025.120206_b0080","first-page":"S1","article-title":"KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases","volume":"100","author":"Kidney Disease: Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group","year":"2021","journal-title":"Kidney Int."},{"issue":"9","key":"10.1016\/j.cca.2025.120206_b0085","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann. Intern. Med."},{"issue":"2","key":"10.1016\/j.cca.2025.120206_b0090","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0021-9150(00)00408-1","article-title":"Two subpopulations of intermediate density lipoprotein and their relationship to plasma triglyceride and cholesterol levels","volume":"153","author":"Meyer","year":"2000","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.cca.2025.120206_b0095","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ijcard.2005.02.035","article-title":"Should we measure routinely the LDL peak particle size","volume":"107","author":"Rizzo","year":"2006","journal-title":"Int. J. Cardiol."},{"issue":"1","key":"10.1016\/j.cca.2025.120206_b0100","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nrneph.2015.180","article-title":"HDL abnormalities in nephrotic syndrome and chronic kidney disease","volume":"12","author":"Vaziri","year":"2016","journal-title":"Nat Rev Nephrol"},{"issue":"3","key":"10.1016\/j.cca.2025.120206_b0105","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s11745-016-4120-6","article-title":"Increased HDL Size and Enhanced Apo A-I Catabolic Rates Are Associated With Doxorubicin-Induced Proteinuria in New Zealand White Rabbits","volume":"51","author":"L\u00f3pez-Olmos","year":"2016","journal-title":"Lipids"},{"key":"10.1016\/j.cca.2025.120206_b0110","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.cca.2012.09.028","article-title":"Shift of high-density lipoprotein size distribution toward large particles in patients with proteinuria","volume":"414","author":"Soto-Miranda","year":"2012","journal-title":"Clin. Chim. Acta"},{"issue":"1","key":"10.1016\/j.cca.2025.120206_b0115","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1186\/s12872-021-02354-2","article-title":"Effect of renal function on high-density lipoprotein particles in patients with coronary heart disease","volume":"21","author":"Jieni","year":"2021","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.cca.2025.120206_b0120","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.atherosclerosis.2015.10.111","article-title":"Cholesterol efflux capacity is an independent predictor of all-cause and cardiovascular mortality in patients with coronary artery disease: A prospective cohort study","volume":"249","author":"Liu","year":"2016","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.cca.2025.120206_b0125","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s11883-015-0554-1","article-title":"HDL Cholesterol Efflux Capacity: Cardiovascular Risk Factor and Potential Therapeutic Target","volume":"18","author":"Bhatt","year":"2016","journal-title":"Curr Atheroscler Rep"},{"issue":"7","key":"10.1016\/j.cca.2025.120206_b0130","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S2213-8587(15)00126-6","article-title":"Association of HDL cholesterol efflux capacity with incident coronary heart disease events: a prospective case-control study","volume":"3","author":"Saleheen","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"2","key":"10.1016\/j.cca.2025.120206_b0135","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/00041433-200004000-00002","article-title":"Structure and function of apolipoprotein A-I and high-density lipoprotein","volume":"11","author":"Segrest","year":"2000","journal-title":"Curr. Opin. Lipidol."},{"issue":"3","key":"10.1016\/j.cca.2025.120206_b0140","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1179\/1351000213Y.0000000048","article-title":"Serum malondialdehyde levels, myeloperoxidase and catalase activities in patients with nephrotic syndrome","volume":"18","author":"Begenik","year":"2013","journal-title":"Redox Rep."},{"issue":"35","key":"10.1016\/j.cca.2025.120206_b0145","doi-asserted-by":"crossref","first-page":"13032","DOI":"10.1073\/pnas.0405292101","article-title":"The myeloperoxidase product hypochlorous acid oxidizes HDL in the human artery wall and impairs ABCA1-dependent cholesterol transport","volume":"101","author":"Bergt","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"24","key":"10.1016\/j.cca.2025.120206_b0150","doi-asserted-by":"crossref","first-page":"18473","DOI":"10.1074\/jbc.M110.118182","article-title":"Modifying apolipoprotein A-I by malondialdehyde, but not by an array of other reactive carbonyls, blocks cholesterol efflux by the ABCA1 pathway","volume":"285","author":"Shao","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"18","key":"10.1016\/j.cca.2025.120206_b0155","doi-asserted-by":"crossref","first-page":"10955","DOI":"10.1016\/S0021-9258(18)33916-4","article-title":"Evidence for the separation of albumin- and apo A-I-dependent mechanisms of cholesterol efflux from cultured fibroblasts into human plasma","volume":"257","author":"Fielding","year":"1982","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cca.2025.120206_b0160","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.plipres.2017.12.001","article-title":"Determinants of cholesterol efflux capacity in humans","volume":"69","author":"Talbot","year":"2018","journal-title":"Prog. Lipid Res."},{"issue":"1","key":"10.1016\/j.cca.2025.120206_b0165","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/MOL.0000000000000382","article-title":"Inflammation, remodeling, and other factors affecting HDL cholesterol efflux","volume":"28","author":"Ronsein","year":"2017","journal-title":"Curr. Opin. Lipidol."},{"issue":"12","key":"10.1016\/j.cca.2025.120206_b0170","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.2215\/CJN.07180622","article-title":"The Immune System and Idiopathic Nephrotic Syndrome","volume":"17","author":"Campbell","year":"2022","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.cca.2025.120206_b0175","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/978-1-4939-2895-8_6","article-title":"How Do Glucocorticoids Regulate Lipid Metabolism","volume":"872","author":"de Guia","year":"2015","journal-title":"Advances in Experimental Medicine and Biology"},{"issue":"1","key":"10.1016\/j.cca.2025.120206_b0180","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/TP.0b013e3181aa7d04","article-title":"Tacrolimus-induced elevation in plasma triglyceride concentrations after administration to renal transplant patients is partially due to a decrease in lipoprotein lipase activity and plasma concentrations","volume":"88","author":"Tory","year":"2009","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.cca.2025.120206_b0185","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1161\/CIRCRESAHA.116.308537","article-title":"Pleiotropic Effects of Statins on the Cardiovascular System","volume":"120","author":"Oesterle","year":"2017","journal-title":"Circ. Res."},{"issue":"2","key":"10.1016\/j.cca.2025.120206_b0190","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1056\/NEJMoa1001689","article-title":"Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis","volume":"364","author":"Khera","year":"2011","journal-title":"N. Engl. J. Med."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898125000853?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898125000853?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T17:14:50Z","timestamp":1741367690000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898125000853"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":38,"alternative-id":["S0009898125000853"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2025.120206","relation":{},"ISSN":["0009-8981"],"issn-type":[{"type":"print","value":"0009-8981"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Proatherogenic changes in the quantity and quality of lipoproteins in adults with idiopathic nephrotic syndrome","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2025.120206","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"120206"}}